| Riluzole, Rilutek
Rilutek (riluzole) is a member of the benzothiazole class.
Rilutek is indicated for the treatment of patients with amyotrophic lateral sclerosis (ALS).
The most commonly observed AEs associated with the use of RILUTEK more frequently than placebo treated patients, were: asthenia, nausea, dizziness, decreased lung function, diarrhea, abdominal pain, pneumonia, vomiting, vertigo, circumoral paresthesia, anorexia, and somnolence. Asthenia, nausea, dizziness, diarrhea, anorexia, vertigo, somnolence, and circumoral paresthesia were dose related.
Fantastic new books!
CAM Therapies has studies on natural therapies for over 100 diseases.
CAM Labs lists lab tests for 100 diseases.
Nutritional Genetics is a fantastic resource.